论文部分内容阅读
2006年以来,药物涂层支架(drug-eluting stents,DES)的安全性问题使许多医生改变了对成千上万心脏病患者的治疗策略,使用率和销售率明显下滑。目前,药物涂层支架的安全性争论已经平息,数据显示其使用率正在稳步回升。本文编译整理了四大主要支架制造商的最新采访记录,讨论药物涂层支架面临的挑战以及前景展望。
Since 2006, the safety of drug-eluting stents (DES) has led many physicians to change their treatment strategy for thousands of heart patients, with a marked decline in usage and sales rates. At present, the debate over the safety of drug-coated stents has subsided, with data showing a steady recovery in usage. This article compiled the latest interviews with the four major stent manufacturers to discuss the challenges and prospects for drug-coated stents.